The MightyMedic (Multidisciplinary International Group for Hemapheresis TherapY and MEtabolic DIsturbances Contrast) Working Group has been founded in 2013. The leading idea was to establish an international network of interdisciplinary nature aimed at working to cross national borders research projects, clinical trials, educational initiatives (meetings, workshops, summer schools) in the field of metabolic diseases, namely hyperlipida emias, and diabetes, preventive cardiology, and atherosclerosis. Therapeutic apheresis, its indications and techniques, is a parallel field of investigation. The first on-line survey of the Group has been completed in the first half of 2014. The survey included # 23 centers in Italy, Germany, Greece, UK, Japan, and USA. 240 subjects with hyperlipidaemia have been reported in the survey.

First on-line survey of an international multidisciplinary working group (MightyMedic) on current practice in diagnosis, therapy and follow-up of dyslipidemias / Stefanutti, Claudia; D'Alessandri, G.; Petta, A.; Harada Shiba, M.; Julius, U.; Soran, H.; Moriarty, P. M.; Romeo, S.; Drogari, E.; Jaeger, B. R.; Bianciardi, G.; Bosco, Giovanna; Cossu, M.; De Fusco, G.; DI GIACOMO, Serafina; Ewald, N.; Gualdi, Gianfranco; Lanti, A.; Marson, P.; Martino, F.; Migliori, G.; Parasassi, A.; Pavan, Antonio; Perla, Francesco Massimo; Perrone, Giuseppina; Pisciotta, L.; Renga, S.; Ries, W.; Null, R. o. m. a. n. o. N.. - In: ATHEROSCLEROSIS SUPPLEMENTS. - ISSN 1567-5688. - 18:(2015), pp. 241-250. [10.1016/j.atherosclerosissup.2015.02.036]

First on-line survey of an international multidisciplinary working group (MightyMedic) on current practice in diagnosis, therapy and follow-up of dyslipidemias

STEFANUTTI, Claudia;BOSCO, Giovanna;DI GIACOMO, SERAFINA;GUALDI, GIANFRANCO;PAVAN, Antonio;PERLA, Francesco Massimo;PERRONE, Giuseppina;
2015

Abstract

The MightyMedic (Multidisciplinary International Group for Hemapheresis TherapY and MEtabolic DIsturbances Contrast) Working Group has been founded in 2013. The leading idea was to establish an international network of interdisciplinary nature aimed at working to cross national borders research projects, clinical trials, educational initiatives (meetings, workshops, summer schools) in the field of metabolic diseases, namely hyperlipida emias, and diabetes, preventive cardiology, and atherosclerosis. Therapeutic apheresis, its indications and techniques, is a parallel field of investigation. The first on-line survey of the Group has been completed in the first half of 2014. The survey included # 23 centers in Italy, Germany, Greece, UK, Japan, and USA. 240 subjects with hyperlipidaemia have been reported in the survey.
2015
Coronary artery disease; Dyslipidemia; Lipoprotein apheresis; Multicenter study; Survey; Cardiology and Cardiovascular Medicine; Internal Medicine
01 Pubblicazione su rivista::01a Articolo in rivista
First on-line survey of an international multidisciplinary working group (MightyMedic) on current practice in diagnosis, therapy and follow-up of dyslipidemias / Stefanutti, Claudia; D'Alessandri, G.; Petta, A.; Harada Shiba, M.; Julius, U.; Soran, H.; Moriarty, P. M.; Romeo, S.; Drogari, E.; Jaeger, B. R.; Bianciardi, G.; Bosco, Giovanna; Cossu, M.; De Fusco, G.; DI GIACOMO, Serafina; Ewald, N.; Gualdi, Gianfranco; Lanti, A.; Marson, P.; Martino, F.; Migliori, G.; Parasassi, A.; Pavan, Antonio; Perla, Francesco Massimo; Perrone, Giuseppina; Pisciotta, L.; Renga, S.; Ries, W.; Null, R. o. m. a. n. o. N.. - In: ATHEROSCLEROSIS SUPPLEMENTS. - ISSN 1567-5688. - 18:(2015), pp. 241-250. [10.1016/j.atherosclerosissup.2015.02.036]
File allegati a questo prodotto
File Dimensione Formato  
Stefanutti_First-on-line_2015.pdf

solo utenti autorizzati

Note: Articolo principale
Tipologia: Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza: Tutti i diritti riservati (All rights reserved)
Dimensione 1.13 MB
Formato Adobe PDF
1.13 MB Adobe PDF   Contatta l'autore

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/808195
Citazioni
  • ???jsp.display-item.citation.pmc??? 0
  • Scopus 5
  • ???jsp.display-item.citation.isi??? 5
social impact